Ami Miller

Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds

Abimael Cruz-Migoni, Peter Canning, Camilo Quevedo et al. · Proceedings of the National Academy of Sciences · 2019 · 139 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment

Camilo Quevedo, Abimael Cruz-Migoni, Nicolas Béry et al. · Nature Communications · 2018 · 131 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS

Nicolas Béry, Ami Miller · Nature Communications · 2020 · 130 citations · Full text

Medicine, Molecular Biology, Oncology +17

Complement Factor H Binds at Two Independent Sites to C-reactive Protein in Acute Phase Concentrations*

Azubuike I. Okemefuna, Ruodan Nan, Ami Miller et al. · Journal of Biological Chemistry · 2009 · 121 citations · Full text

Life Sciences, Immunology, Molecular Biology +15

KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe

Nicolas Béry, Sandrine Legg, J.E. Debreczeni et al. · Nature Communications · 2019 · 96 citations · Full text

Medicine, Molecular Biology, Oncology +17